tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Arrowhead Pharmaceuticals Inc

ARWR
Add to Watchlist
84.650USD
-2.670-3.06%
Close 07-31 16:00（ET）Quotes delayed by 15 min
11.92BMarket Cap
LossP/E TTM

Arrowhead Pharmaceuticals Inc

84.650
-2.670-3.06%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ARWR Financials

See Arrowhead Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Arrowhead Pharmaceuticals Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/-1.32
Revenue / Forecast
--/54.29M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
829.45M
23258.15%
EPS(YoY)
-0.01
99.76%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-133.55%-0.93
116.22%0.22
87.44%-0.17
8.35%-1.26
373.31%2.78
-12.08%-1.39
-34.05%-1.37
-42.94%-1.38
-322.91%-1.02
-217.39%-1.24
---1.02
---0.96
--0.46
---0.39
---1.67
----
----
----
----
----
Revenue
-86.41%73.74M
10461.32%264.03M
--256.47M
--27.77M
--542.71M
-29.60%2.50M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-94.32%3.55M
-49.02%16.10M
-51.18%15.82M
-3.65%146.27M
127.95%62.55M
-17.52%31.57M
-29.37%32.41M
362.66%151.81M
28.80%27.44M
401.56%38.28M
67.63%45.89M
Net Profit
-135.83%-132.73M
117.80%30.81M
86.07%-23.75M
-2.60%-175.24M
395.65%370.44M
-30.27%-173.09M
-55.49%-170.54M
-65.91%-170.79M
-357.42%-125.30M
-221.51%-132.86M
-28.26%-109.68M
-42.89%-102.95M
9.71%48.67M
34.27%-41.33M
-34.93%-85.51M
-140.76%-72.05M
265.43%44.37M
-203.26%-62.87M
-30.85%-63.37M
-119.85%-29.92M
Net Margin
-375.25%-186.57%
100.15%10.70%
--6.29%
---643.40%
--67.78%
-83.84%-7008.72%
----
----
----
-5602.96%-3812.33%
---689.66%
---657.98%
--32.60%
---66.85%
---72.56%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
0.00%100.00%
----
----
----
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
220.46%55.79%
-10.77%36.04%
30.22%44.92%
--43.50%
--17.41%
--40.39%
--34.50%
----
----
----
----
--33.05%
----
----
----
----
----
----
----
----
Income Statement
Revenue
-86.41%73.74M
10461.32%264.03M
--256.47M
--27.77M
--542.71M
-29.60%2.50M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-94.32%3.55M
-49.02%16.10M
-51.18%15.82M
-3.65%146.27M
127.95%62.55M
-17.52%31.57M
-29.37%32.41M
362.66%151.81M
28.80%27.44M
401.56%38.28M
67.63%45.89M
Operating profit
-137.06%-141.26M
125.28%40.81M
127.19%44.11M
6.01%-165.55M
402.08%381.20M
-18.21%-161.41M
-49.73%-162.20M
-71.51%-176.14M
-362.00%-126.19M
-224.07%-136.54M
-29.23%-108.33M
-40.86%-102.70M
15.91%48.16M
33.46%-42.13M
-29.20%-83.83M
-128.78%-72.91M
247.18%41.55M
-163.25%-63.32M
-29.46%-64.88M
-99.85%-31.87M
Net Profit
-135.83%-132.73M
117.80%30.81M
86.07%-23.75M
-2.60%-175.24M
395.65%370.44M
-30.27%-173.09M
-55.49%-170.54M
-65.91%-170.79M
-357.42%-125.30M
-221.51%-132.86M
-28.26%-109.68M
-42.89%-102.95M
9.71%48.67M
34.27%-41.33M
-34.93%-85.51M
-140.76%-72.05M
265.43%44.37M
-203.26%-62.87M
-30.85%-63.37M
-119.85%-29.92M
Balance Sheet
Current assets
62.06%1.84B
105.84%1.17B
36.69%950.64M
110.40%946.92M
109.59%1.14B
139.82%570.54M
65.78%695.47M
-4.28%450.06M
-5.77%541.65M
-58.63%237.90M
3.51%419.52M
8.74%470.17M
37.64%574.81M
69.98%575.00M
5.38%405.30M
-17.79%432.39M
-28.82%417.63M
4.50%338.28M
19.30%384.60M
66.85%525.96M
Total current liabilities
33.86%295.22M
270.56%347.43M
89.48%195.49M
101.14%194.53M
238.38%220.54M
47.13%93.76M
-2.17%103.17M
37.72%96.71M
-25.22%65.17M
-47.77%63.72M
-24.05%105.46M
-45.23%70.23M
-37.24%87.15M
-10.96%122.01M
-5.25%138.85M
-34.40%128.21M
-16.95%138.86M
446.07%137.03M
260.20%146.54M
356.80%195.43M
Total assets
44.15%2.27B
58.25%1.60B
21.54%1.39B
56.22%1.38B
64.74%1.57B
61.86%1.01B
48.89%1.14B
11.05%883.76M
7.16%955.15M
-29.75%626.29M
10.64%765.55M
5.86%795.86M
26.68%891.31M
39.61%891.49M
-2.56%691.94M
2.29%751.78M
-7.03%703.58M
27.90%638.54M
35.91%710.15M
32.25%734.93M
Total liabilities
87.72%1.67B
8.76%1.04B
-7.05%881.88M
58.01%860.81M
93.43%889.27M
111.59%957.62M
98.32%948.74M
31.63%544.78M
7.87%459.75M
-8.59%452.57M
74.85%478.39M
49.09%413.87M
69.59%426.20M
86.15%495.12M
-9.20%273.60M
-6.86%277.61M
-19.26%251.31M
493.98%265.98M
396.22%301.33M
372.00%298.04M
Total equity
-12.47%598.92M
903.47%562.70M
163.48%503.42M
53.35%519.81M
38.11%684.23M
-67.72%56.08M
-33.47%191.06M
-11.26%338.97M
6.51%495.40M
-56.17%173.71M
-31.36%287.16M
-19.44%381.99M
2.84%465.11M
6.39%396.37M
2.33%418.34M
8.53%474.18M
1.51%452.27M
-18.02%372.56M
-11.47%408.82M
-11.31%436.89M
Cash Flow Statement
Net operating income
-81.65%84.44M
109.22%13.48M
114.93%20.49M
-34.05%-154.72M
598.02%460.05M
-24.13%-146.27M
-443.28%-137.22M
-438.18%-115.42M
-191.68%-92.38M
-56.05%-117.84M
63.22%-25.26M
68.85%-21.45M
-150.49%-31.67M
-23.10%-75.52M
-184.72%-68.67M
-132.51%-68.85M
-76.23%62.73M
-57.62%-61.35M
-122.28%-24.12M
11.42%-29.61M
Net investment
-112.82%-894.28M
-130.87%-23.74M
132.58%72.62M
1934.68%141.39M
-56.25%-420.21M
18.62%76.91M
-830.68%-222.92M
170.16%6.95M
-645.70%-268.94M
180.35%64.84M
-16.29%30.51M
-116.16%-9.90M
48.30%-36.06M
-141.71%-80.69M
130.82%36.45M
413.59%61.28M
-104.86%-69.75M
-210.70%-33.38M
-79.45%-118.25M
-223.86%-19.54M
Net financing
761.33%795.72M
-171.48%-14.75M
-99.06%3.67M
-184.70%-42.68M
-78.55%92.38M
7628.09%20.63M
255879.61%389.09M
2691.52%50.39M
82741.73%430.78M
-99.89%267.00K
-82.22%152.00K
-97.02%1.81M
-71.83%520.00K
13193.16%250.58M
4.91%855.00K
2099.64%60.60M
-29.89%1.85M
-63.05%1.89M
-18.86%815.00K
29.17%2.75M

FAQs

What is the total revenue of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 829.45M, with a year-on-year change of 3.55M.

What are the current assets of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its current assets were 950.64M, with a year-on-year change of 36.69.

What are the total assets of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its total assets of Arrowhead Pharmaceuticals Inc were 1.39B, with a year-on-year change of 21.54.

What are the total liabilities of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Arrowhead Pharmaceuticals Inc were 881.88M, with a year-on-year change of -7.05.

What is the total equity of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its total equity of Arrowhead Pharmaceuticals Inc was 503.42M, with a year-on-year change of 163.48.

What is the net operating income of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Arrowhead Pharmaceuticals Inc was 98.35M, with a year-on-year change of 116.36.

What is the net investment of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its net investment of Arrowhead Pharmaceuticals Inc was -129.29M, with a year-on-year change of 69.22.

What is the net financing of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its net financing of Arrowhead Pharmaceuticals Inc was 74.01M, with a year-on-year change of -91.50.

What is the Earnings Per Share (EPS) of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.01, with a year-on-year change of 99.76.

What is the net income of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its net income was -1.63M, with a year-on-year change of 99.73.

What is the net margin of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 3.63, with a year-on-year change of 100.02.

What is the debt-to-asset ratio of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 44.92, with a year-on-year change of -30.30.

What is the Return on Equity (ROE) of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -0.50, with a year-on-year change of 99.81.

What is the Return on Assets (ROA) of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 2.39, with a year-on-year change of 103.73.

What is the operating profit of Arrowhead Pharmaceuticals Inc?

According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 98.35M, with a year-on-year change of 116.36.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy